-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Upgrades Haemonetics to Buy, Raises Price Target to $123

Benzinga·09/17/2026 13:27:18
Listen to the news
Citigroup analyst Joanne Wuensch upgrades Haemonetics (NYSE:HAE) from Neutral to Buy and raises the price target from $92 to $123.